Cerevel Therapeutics Holdings Inc logo

Cerevel Therapeutics Holdings Inc

1
1
NAS:CERE (USA)   Ordinary Shares
$ 42.23 -0.15 (-0.35%) 10:24 AM EST
At Loss
P/B:
11.35
Volume:
164.24K
Avg Vol (2M):
1.56M
Also Trade In:
Volume:
164.24K
At Loss
Avg Vol (2M):
1.56M

Business Description

Cerevel Therapeutics Holdings Inc logo
Cerevel Therapeutics Holdings Inc
NAICS : 541714 SIC : 2834
ISIN : US15678U1280

Share Class Description:

CERE: Ordinary Shares
Description
Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.
Name Current Vs Industry Vs History
Cash-To-Debt 2.69
Equity-to-Asset 0.54
Debt-to-Equity 0.55
Debt-to-EBITDA -0.89
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.6
9-Day RSI 62.48
14-Day RSI 59.89
6-1 Month Momentum % 96.22
12-1 Month Momentum % 75.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.92
Quick Ratio 10.92
Cash Ratio 10.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.6
Shareholder Yield % -2.16
Name Current Vs Industry Vs History
ROE % -96.18
ROA % -44.1
ROIC % -278.37
ROC (Joel Greenblatt) % -882.54
ROCE % -46.49

Financials (Next Earnings Date:2024-05-03 Est.)

CERE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CERE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cerevel Therapeutics Holdings Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.67
Beta 1.35
Volatility % 74.13
14-Day RSI 59.89
14-Day ATR ($) 0.361172
20-Day SMA ($) 41.849
12-1 Month Momentum % 75.39
52-Week Range ($) 19.59 - 43.5898
Shares Outstanding (Mil) 181.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cerevel Therapeutics Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Cerevel Therapeutics Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cerevel Therapeutics Holdings Inc Frequently Asked Questions

What is Cerevel Therapeutics Holdings Inc(CERE)'s stock price today?
The current price of CERE is $42.23. The 52 week high of CERE is $43.59 and 52 week low is $19.59.
When is next earnings date of Cerevel Therapeutics Holdings Inc(CERE)?
The next earnings date of Cerevel Therapeutics Holdings Inc(CERE) is 2024-05-03 Est..
Does Cerevel Therapeutics Holdings Inc(CERE) pay dividends? If so, how much?
Cerevel Therapeutics Holdings Inc(CERE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1